Characteristics | Â | No. | NGF | Â | HO1 | Â |
---|---|---|---|---|---|---|
 |  |  | Positive | P | Positive | P |
Age, y | <50 | 104 | 27 (26%) | 0.035 | 45 (43%) | 0.029 |
 | ≥50 | 41 | 18 (44%) |  | 26 (63%) |  |
TNM stage | I | 29 | 9 (31%) | 0.836 | 17 (59%) | 0.507 |
 | II | 97 | 28 (29%) |  | 45 (46%) |  |
 | III and IV | 19 | 7 (37%) |  | 9 (47%) |  |
T stage | 1 | 41 | 10 (24%) | 0.424 | 22 (54%) | 0.675 |
 | 2 | 95 | 31 (33%) |  | 44 (46%) |  |
 | 3 and 4 | 9 | 4 (44%) |  | 5 (56%) |  |
LN metastasis | Absence | 83 | 26 (31%) | 0.930 | 39 (47%) | 0.582 |
 | Presence | 62 | 19 (31%) |  | 32 (52%) |  |
Latent distant metastasis | Absence | 112 | 28 (25%) | 0.004 | 45 (40%) | < 0.001 |
 | Presence | 33 | 17 (52%) |  | 26 (79%) |  |
Histologic type | Ductal | 137 | 43 (31%) | 0.704 | 67 (49%) | 0.952 |
 | Lobular | 8 | 2 (25%) |  | 4 (50%) |  |
Histologic grade | 1 | 49 | 9 (18%) | 0.020 | 20 (41%) | 0.017 |
 | 2 | 67 | 22 (33%) |  | 30 (45%) |  |
 | 3 | 29 | 14 (48%) |  | 21 (72%) |  |
HER2 | Negative | 105 | 25 (24%) | 0.002 | 42 (40%) | < 0.001 |
 | Positive | 40 | 20 (50%) |  | 29 (73%) |  |
ER | Negative | 65 | 28 (43%) | 0.005 | 35 (54%) | 0.289 |
 | Positive | 80 | 17 (21%) |  | 36 (45%) |  |
PR | Negative | 60 | 23 (38%) | 0.110 | 34 (57%) | 0.119 |
 | Positive | 85 | 22 (26%) |  | 37 (44%) |  |
HO1 | Negative | 74 | 5 (7%) | < 0.001 | Â | Â |
 | Positive | 71 | 40 (56%) |  |  |  |